News

Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...
Buy, Sell, Or Hold Eli Lilly Stock At $820?
The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve ...
Fierce Biotech3h
Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial
Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
The implications for Eli Lilly and Novo Nordisk seem pretty clear: The immediate removal of a rival for the massive revenues ...
Eli Lilly: Still Great, But Still Too Expensive Even As Earnings Near
Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See ...
StockStory.org on MSN6d
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White ...